Huge drug (pharma) money changes hands in high-level financial deals—why?
Huge drug (pharma) money changes hands in high-level financial deals—why? by Jon Rappoport These are notes on money-musical-chairs among drug companies. Big-time money. Clues as to why there is such a tidal wave of cash: […]